Skip to content
Disclosery

Boxer Capital, LLC

Follow

13F filer, CIK 1465837, San Diego, CA

Boxer Capital, LLC reported $1,878,507,388 across 73 holdings for the quarter ended 2023-09-30, in a 13F-HR filed 2023-11-14. Its ten largest share positions make up 47.5% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000895345-23-000631

Period
2023-09-30
Reported value
$1.88B
Holdings
73
Top 10 weight
47.5%
New
5
Sold out
11

Largest buys vs the previous quarter

SecurityShares changeApprox. value
MIRATI THERAPEUTICS INCadded+1,201,440$52.3M
XBInew+500,000$36.5M
IMVTnew+750,000$28.8M
PRTAadded+325,000$15.7M
ABOSnew+2,206,983$9.16M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
REATA PHARMACEUTICALS INCexited-1,430,004-$146M
89BIO INCexited-2,100,000-$39.8M
IVERIC BIO INCexited-825,000-$32.5M
CABAexited-540,000-$6.97M
IRONexited-130,000-$5.77M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2023

Share positions as resolved from 13F-HR 0000895345-23-000631, largest first. % of portfolio is the value over $1,878,507,388, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MIRATI THERAPEUTICS INCMIRATI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,000,000 shares; 2023Q2: 2,000,000 shares; 2023Q3: 3,201,440 shares 3,201,440$139M7.42%+1,201,440
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 4,684,264 shares; 2023Q2: 4,684,264 shares; 2023Q3: 4,684,264 shares 4,684,264$130M6.9%0Timeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 500,000 shares; 2023Q2: 500,000 shares; 2023Q3: 500,000 shares 500,000$89.9M4.79%0Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 6,448,359 shares; 2023Q2: 6,448,359 shares; 2023Q3: 6,448,359 shares 6,448,359$88.8M4.73%0Timeline
AKROAKERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 831,495 shares; 2023Q2: 1,676,733 shares; 2023Q3: 1,676,733 shares 1,676,733$84.8M4.51%0Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 7,123,642 shares; 2023Q2: 7,123,642 shares; 2023Q3: 7,123,642 shares 7,123,642$80.2M4.27%0Timeline
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 3,421,541 shares; 2023Q2: 3,421,541 shares; 2023Q3: 3,421,541 shares 3,421,541$79.1M4.21%0
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 775,000 shares; 2023Q2: 600,000 shares; 2023Q3: 600,000 shares 600,000$72.7M3.87%0Timeline
APLSAPELLIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,576,000 shares; 2023Q2: 1,576,000 shares; 2023Q3: 1,726,000 shares 1,726,000$65.7M3.5%+150,000Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,100,000 shares; 2023Q2: 2,100,000 shares; 2023Q3: 2,100,000 shares 2,100,000$61.9M3.29%0Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,202,812 shares; 2023Q2: 2,202,812 shares; 2023Q3: 2,202,812 shares 2,202,812$59.4M3.16%0Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,210,192 shares; 2023Q2: 1,210,192 shares; 2023Q3: 1,210,192 shares 1,210,192$55.6M2.96%0Timeline
IMMUNOGEN INCIMMUNOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 2,961,000 shares; 2023Q3: 2,961,000 shares 2,961,000$47M2.5%0
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,900,000 shares; 2023Q2: 1,900,000 shares; 2023Q3: 1,900,000 shares 1,900,000$44.8M2.38%0
KARUNA THERAPEUTICS INCKARUNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 250,000 shares; 2023Q3: 250,000 shares 250,000$42.3M2.25%0
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 75,000 shares; 2023Q3: 85,000 shares 85,000$41.8M2.22%+10,000Timeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 600,000 shares; 2023Q3: 600,000 shares 600,000$40.3M2.15%0Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,084,000 shares; 2023Q2: 2,084,000 shares; 2023Q3: 2,084,000 shares 2,084,000$38.2M2.03%0Timeline
XBISPDR SERIES TRUSTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 500,000 shares 500,000$36.5M1.94%newTimeline
PRTAPROTHENA CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 300,000 shares; 2023Q2: 300,000 shares; 2023Q3: 625,000 shares 625,000$30.2M1.61%+325,000Timeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,466,051 shares; 2023Q2: 1,466,051 shares; 2023Q3: 1,466,051 shares 1,466,051$30M1.6%0Timeline
VTYXVENTYX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 850,000 shares; 2023Q2: 850,000 shares; 2023Q3: 850,000 shares 850,000$29.5M1.57%0Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 750,000 shares 750,000$28.8M1.53%newTimeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,432,200 shares; 2023Q2: 1,602,200 shares; 2023Q3: 1,602,200 shares 1,602,200$28.8M1.53%0Timeline
FOLDAMICUS THERAPEUTICQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,325,000 shares; 2023Q2: 2,325,000 shares; 2023Q3: 2,325,000 shares 2,325,000$28.3M1.51%0Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 400,000 shares; 2023Q2: 400,000 shares; 2023Q3: 400,000 shares 400,000$28M1.49%0Timeline
EXELEXELIXIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,150,000 shares; 2023Q2: 1,150,000 shares; 2023Q3: 1,150,000 shares 1,150,000$25.1M1.34%0Timeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,300,000 shares; 2023Q2: 1,300,000 shares; 2023Q3: 1,300,000 shares 1,300,000$23.3M1.24%0Timeline
SAGE THERAPEUTICS INCSAGE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,094,000 shares; 2023Q2: 1,094,000 shares; 2023Q3: 1,094,000 shares 1,094,000$22.5M1.2%0
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,000,000 shares; 2023Q2: 2,000,000 shares; 2023Q3: 2,000,000 shares 2,000,000$22.1M1.18%0Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 600,000 shares; 2023Q2: 600,000 shares; 2023Q3: 600,000 shares 600,000$20.5M1.09%0Timeline
ITEOS THERAPEUTICS INCITEOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,154,058 shares; 2023Q2: 2,154,058 shares; 2023Q3: 1,804,058 shares 1,804,058$19.8M1.05%-350,000
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 3,163,795 shares; 2023Q2: 3,163,795 shares; 2023Q3: 3,163,795 shares 3,163,795$19.4M1.03%0Timeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 3,705,133 shares; 2023Q2: 3,705,133 shares; 2023Q3: 3,705,133 shares 3,705,133$16.9M0.9%0Timeline
POINT BIOPHARMA GLOBAL INCPOINT BIOPHARMA GLOBAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,500,000 shares; 2023Q2: 2,500,000 shares; 2023Q3: 2,500,000 shares 2,500,000$16.7M0.89%0
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,650,000 shares; 2023Q2: 1,650,000 shares; 2023Q3: 1,650,000 shares 1,650,000$15.9M0.85%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,169,132 shares; 2023Q2: 1,819,132 shares; 2023Q3: 1,819,132 shares 1,819,132$15.3M0.81%0Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 100,000 shares; 2023Q3: 100,000 shares 100,000$14.6M0.78%0Timeline
DAWNDAY ONE BIOPHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,189,943 shares; 2023Q2: 1,189,943 shares; 2023Q3: 1,189,943 shares 1,189,943$14.6M0.78%0Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,054,000 shares; 2023Q2: 1,732,571 shares; 2023Q3: 1,732,571 shares 1,732,571$10.5M0.56%0Timeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,074,082 shares; 2023Q2: 1,074,082 shares; 2023Q3: 1,074,082 shares 1,074,082$9.72M0.52%0Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,224,892 shares; 2023Q2: 1,224,892 shares; 2023Q3: 1,224,892 shares 1,224,892$9.63M0.51%0Timeline
ABOSACUMEN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 2,206,983 shares 2,206,983$9.16M0.49%newTimeline
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 450,000 shares; 2023Q3: 450,000 shares 450,000$9.03M0.48%0Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 95,000 shares; 2023Q2: 95,000 shares; 2023Q3: 95,000 shares 95,000$8.9M0.47%0Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 710,644 shares; 2023Q2: 710,644 shares; 2023Q3: 646,058 shares 646,058$8.83M0.47%-64,586Timeline
PRLDPRELUDE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 699,047 shares; 2023Q2: 2,495,018 shares; 2023Q3: 2,495,018 shares 2,495,018$7.71M0.41%0Timeline
RNAMAVIDITY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,121,327 shares; 2023Q2: 1,121,327 shares; 2023Q3: 1,121,327 shares 1,121,327$7.15M0.38%0Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 3,000,000 shares; 2023Q3: 3,000,000 shares 3,000,000$6.36M0.34%0Timeline
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 3,336,928 shares; 2023Q2: 3,336,928 shares; 2023Q3: 6,497,700 shares 6,497,700$5.41M0.29%+3,160,772Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 525,000 shares; 2023Q2: 525,000 shares; 2023Q3: 525,000 shares 525,000$5.12M0.27%0Timeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,251,137 shares; 2023Q2: 1,251,137 shares; 2023Q3: 770,708 shares 770,708$4.99M0.27%-480,429Timeline
RAPT THERAPEUTICS INCRAPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 300,000 shares; 2023Q2: 300,000 shares; 2023Q3: 300,000 shares 300,000$4.99M0.27%0
THRDTHIRD HARMONIC BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 570,417 shares; 2023Q2: 570,417 shares; 2023Q3: 520,417 shares 520,417$3.33M0.18%-50,000Timeline
Mersana Therapeutics IncMersana Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 1,000,000 shares; 2023Q3: 2,000,000 shares 2,000,000$2.54M0.14%+1,000,000
EQRX INCEQRX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,000,000 shares; 2023Q2: 1,000,000 shares; 2023Q3: 1,000,000 shares 1,000,000$2.22M0.12%0
OBIOORCHESTRA BIOMED HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 250,000 shares; 2023Q2: 250,000 shares; 2023Q3: 238,193 shares 238,193$2.08M0.11%-11,807Timeline
2SEVENTY BIO INC COMMON STO…2SEVENTY BIO INC COMMON STOCKQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 459,836 shares; 2023Q2: 459,836 shares; 2023Q3: 459,836 shares 459,836$1.8M0.1%0
BDTXBLACK DIAMOND THERAPEUTICS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,014,858 shares; 2023Q2: 2,014,858 shares; 2023Q3: 506,000 shares 506,000$1.45M0.08%-1,508,858Timeline
DBV TECHNOLOGIES S ADBV TECHNOLOGIES S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,450,000 shares; 2023Q2: 1,450,000 shares; 2023Q3: 985,100 shares 985,100$1.34M0.07%-464,900
BCABBIOATLA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 686,347 shares; 2023Q2: 686,347 shares; 2023Q3: 686,347 shares 686,347$1.17M0.06%0Timeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 600,000 shares 600,000$1.08M0.06%newTimeline
FATEFATE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 500,000 shares; 2023Q2: 500,000 shares; 2023Q3: 500,000 shares 500,000$1.06M0.06%0Timeline
RAIN ONCOLOGY INCRAIN ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,147,212 shares; 2023Q2: 1,152,212 shares; 2023Q3: 1,152,212 shares 1,152,212$993K0.05%0
MISTMILESTONE PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 698,861 shares; 2023Q2: 698,861 shares; 2023Q3: 309,007 shares 309,007$958K0.05%-389,854Timeline
VERRICA PHARMACEUTICALS INCVERRICA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 166,955 shares 166,955$649K0.03%new
ATRECA INCATRECA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,202,333 shares; 2023Q2: 2,202,333 shares; 2023Q3: 2,202,333 shares 2,202,333$575K0.03%0
NGM BIOPHARMACEUTICALS INCNGM BIOPHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 500,000 shares; 2023Q2: 500,000 shares; 2023Q3: 500,000 shares 500,000$535K0.03%0
THESEUS PHARMACEUTICALS INCTHESEUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 350,000 shares; 2023Q2: 350,000 shares; 2023Q3: 150,000 shares 150,000$404K0.02%-200,000
TARAPROTARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 209,227 shares; 2023Q2: 209,227 shares; 2023Q3: 209,227 shares 209,227$349K0.02%0Timeline
ZIOPHARM ONCOLOGY INCZIOPHARM ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,500,000 shares; 2023Q2: 1,500,000 shares; 2023Q3: 1,100,000 shares 1,100,000$145K0.01%-400,000
NUVATION BIO INCNUVATION BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 266,666 shares; 2023Q2: 266,666 shares; 2023Q3: 266,666 shares 266,666$26.7K<0.01%0
SRZNWSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 66,666 shares; 2023Q2: 66,666 shares; 2023Q3: 66,666 shares 66,666$2.75K<0.01%0Timeline

Sold out in Q3 2023

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
REATA PHARMACEUTICALS INCREATA PHARMACEUTICALS INC1,430,004$146Mshares
89BIO INC89BIO INC2,100,000$39.8Mshares
IVERIC BIO INCIVERIC BIO INC825,000$32.5Mshares
CABACABALETTA BIO INC540,000$6.97Mshares
IRONDISC MEDICINE INC130,000$5.77Mshares
SELECTA BIOSCIENCES INCSELECTA BIOSCIENCES INC3,284,072$3.68Mshares
MREOMEREO BIOPHARMA GROUP PLC2,250,000$2.97Mshares
KINNATE BIOPHARMA INCKINNATE BIOPHARMA INC491,000$1.49Mshares
MEI PHARMA INCMEI PHARMA INC145,654$958Kshares
Veru IncVeru Inc347,300$413Kshares
BELLICUM PHARMACEUTICALS IN…BELLICUM PHARMACEUTICALS INC COM …450,000$167Kshares

How Q3 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000895345-23-000631 base2023-11-14acceptance time not in the bulk data set